Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Plus Therapeutics (PSTV) Other Non Operating Income (2016 - 2022)

Plus Therapeutics (PSTV) has disclosed Other Non Operating Income for 11 consecutive years, with $1000.0 as the latest value for Q1 2022.

  • On a quarterly basis, Other Non Operating Income fell 50.0% to $1000.0 in Q1 2022 year-over-year; TTM through Dec 2022 was $3000.0, a N/A change, with the full-year FY2022 number at $1000.0, down 83.33% from a year prior.
  • Other Non Operating Income was $1000.0 for Q1 2022 at Plus Therapeutics, down from $2000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $352000.0 in Q1 2018 to a low of -$204000.0 in Q2 2018.
  • A 4-year average of $41750.0 and a median of $5500.0 in 2018 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 113.33% in 2018; the steepest drop was 423.81% in 2018.
  • Plus Therapeutics' Other Non Operating Income stood at $23000.0 in 2018, then soared by 547.83% to $149000.0 in 2019, then tumbled by 98.66% to $2000.0 in 2021, then plummeted by 50.0% to $1000.0 in 2022.
  • Per Business Quant, the three most recent readings for PSTV's Other Non Operating Income are $1000.0 (Q1 2022), $2000.0 (Q3 2021), and $2000.0 (Q1 2021).